Companies

Crinetics Pharmaceuticals

Mentioned in 1 analyzed podcast episode across 1 show

Mentioned On

Episode Mentions

The Top Line

The Top Line · Jul 10, 2026

A $10B deal, China trial scrutiny and highlights from ADA 2026

Acquired by Vertex for $10B; brings approved endocrine drug Pelsonify and investigational CAH/Cushing syndrome treatment

Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes
View Analysis